Text Size

Drug Eluting Stent Registry of Thrombosis (DESERT)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Medstar Research Institute
ClinicalTrials.gov Identifier:
NCT00812552
First received: December 18, 2008
Last updated: April 22, 2013
Last verified: April 2013
History of Changes
  Purpose

Multicenter, case-control study, to collect data regarding incidences of late and very late drug-eluting stent thrombosis with the aim of identifying trends and possible correlates of stent thrombosis.


Condition
Coronary Artery Disease

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Retrospective
Official Title: Drug Eluting Stent Registry of Thrombosis

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Medstar Research Institute:

Primary Outcome Measures:
  • To assess for potential correlates surrounding subjects and lesions among patients that experience late or very late drug-eluting stent thrombosis [ Time Frame: Baseline ] [ Designated as safety issue: No ]

Enrollment: 984
Study Start Date: September 2009
Study Completion Date: May 2012
Primary Completion Date: May 2012 (Final data collection date for primary outcome measure)
Groups/Cohorts
Case
Late or very late drug-eluting stent thrombosis
Control
No drug-eluting stent thrombosis

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients, male or female, over 18 years of age, who are either known to have experienced late or very late drug-eluting stent thrombosis (Case), or have undergone drug-eluting stent implantation at the same facility, in the same time period as a matched Case Subject, and have not experienced drug-eluting stent thrombosis (Control).

Criteria

Inclusion Criteria:

  • Patients over 18 years of age
  • Case Subjects: patients who have experienced definite late or very late drug-eluting stent thrombosis
  • Control Subjects: patients who underwent drug-eluting stent implantation at the same facility and in the same time period as a matched Case Subject, and have not experienced drug-eluting stent thrombosis.

Exclusion Criteria:

  • Patients not meeting the above Inclusion Criteria
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00812552

  Show 20 Study Locations
Sponsors and Collaborators
Medstar Research Institute
  More Information

No publications provided

Responsible Party: Medstar Research Institute
ClinicalTrials.gov Identifier: NCT00812552     History of Changes
Other Study ID Numbers: DESERT
Study First Received: December 18, 2008
Last Updated: April 22, 2013
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Coronary Artery Disease
Myocardial Ischemia
Coronary Disease
Thrombosis
Heart Diseases
 Cardiovascular Diseases
Arteriosclerosis
Arterial Occlusive Diseases
Vascular Diseases
Embolism and Thrombosis

ClinicalTrials.gov processed this record on May 23, 2013